Skip to main content

Table 1 Patient characteristics, cohort 1 (peripheral blood samples)

From: CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression

Characteristic

Stable MM disease (n = 29)

Progressive MM disease (n = 32)

Median age, years (range)

63.96 (39–84)

63.75 (32–82)

Gender

  

 Male

66% (19)

69% (22)

 Female

34% (10)

31% (10)

Myeloma type

  

 IgG

52% (15)

50% (16)

 IgA

17% (5)

19% (6)

 Light chain only

24% (7)

15.5% (5)

 Missing data

7% (2)

15.5% (5)

% MM cells in BM, range

40% (5–75%)

40% (10–75%)

Extramedullary disease

17% (5)

9.3% (3)

Bone lesions

48.3% (14)

59.3% (19)

Number of previous therapies (range)

2.5 (1–3)

3.5 (2–4)

  1. MM, multiple myeloma; BM, bone marrow; IgG, immunoglobulin G; IgA, immunoglobulin A